»ù±¾ÐÅÏ¢£º
ÖÐÎÄÃû³Æ (S)-2-¼×»ù-CBS-¶ñßòÅðÍé
ÖÐÎıðÃû (S)-5,5-Áª±½-2-¼×»ù-3,4-±û´¼-1,3,2-¶ñßòÅðÍé;(S)-5,5-Áª±½-2-¼×»ù-3,4-±û´¼-1,3,2-¶ñßòÅðÍé;(S)-2-¼×»ù-CBS-ÑõÔÓÅðà¤;2-¼×»ù-CBS-ÑõÔÓÅðà¤;S-2-¼×»ù-CBS-¶ñßòÅðÍé;(S)-(-)-2-¼×»ù-CBS-‡fßòÅðÍé;(S)-2-¼×»ù-CBS-ÑõÔÓÅðव¥Ë®ºÏÎï;(S)-¼×»ù¶ñßòÅðÍé;(S)-(+)-¼×»ù-CBS-¶ñßòÅðÍé;
Ó¢ÎÄÃû³Æ (S)-3,3-Diphenyl-1-methylpyrrolidino[1,2-c]-1,3,2-oxazaborole
Ó¢ÎıðÃû (S)-5,5-Diphenyl-2-Methyl-3,4-propano-1,3,2-oxazaborolidine;(S)-(-)-2-Methyl-CBS-oxazaborolidine;(3aS)-1-methyl-3,3-diphenyl-3a,4,5,6-tetrahydropyrrolo[1,2-c][1,3,2]oxazaborole;(S)-2-Methyl-CBS-oxazaborolidine;(S)-3,3-Diphenyl-1-methyltetrahydro-1H,3H-pyrrolo[1,2-c][1,3,2]oxazaborole;(S)-Tetrahydro-1-Methyl-3,3-Triphenyl-1H,3H-Pyrrolo[1,2-c][1,3,2]Oxazaborole;
CASºÅ 112022-81-8
ºÏ³É·Ïߣº
1.ͨ¹ý(R)-(+)-¦Á,¦Á-¶þ±½»ù¸¬°±´¼ºÍÈý¼×»ù»·ÈýÅðÑõÍéºÏ³É(S)-2-¼×»ù-CBS-¶ñßòÅðÍé
2.ͨ¹ý(R)-(+)-¦Á,¦Á-¶þ±½»ù¸¬°±´¼ºÏ³É(S)-2-¼×»ù-CBS-¶ñßòÅðÍ飬ÊÕÂÊÔ¼89%£»
ÖлªÊÔ¼ÁÍøÌáÐÑ£ººÏ³É·Ïß½ö¹©²Î¿¼